Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure

被引:27
|
作者
Samouilidou, E
Grapsa, E
机构
[1] Alexandra Hosp, Biochem Dept, GR-11528 Athens, Greece
[2] Alexandra Hosp, Renal Unit, GR-11528 Athens, Greece
关键词
hemodialysis; peritoneal dialysis; total antioxidant capacity; malonaldehyde; 4-hydroxyalkenals;
D O I
10.1159/000070691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dialysis is associated with an impairment of antioxidant defense and an overproduction of oxidative stress markers. This study focuses on the comparison of plasma total antioxidant capacity (TAC) and lipid peroxidation products in patients on hemodialysis (HD) before and after treatment and in peritoneal dialysis (PD) patients. Plasma TAC, malonaldehyde (MDA), and 4-hydroxyalkenal concentrations were measured in 31 HD patients, in 24 PD patients, and in 17 normal controls (NC). It was found that before HD, TAC and MDA levels were higher than those in the NC (p < 0.001). After HD, these levels decreased significantly but were higher than in NC and lower than in PD patients (p < 0.001). The levels of 4-hydroxyalkenals were elevated in patients as compared with NC, but did not differ between HD and PD patients. The MDA concentrations correlated positively with the TAC in the patients. It is concluded that the oxidative status of patients on HD is similar to that of patients on PD and that the susceptibility to oxidative stress is strongly related to the levels of MDA produced in plasma. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [21] Acute effect of nut consumption on plasma total polyphenols, antioxidant capacity and lipid peroxidation
    Torabian, S.
    Haddad, E.
    Rajaram, S.
    Banta, J.
    Sabate, J.
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2009, 22 (01) : 64 - 71
  • [22] RESULTS OF DIALYSIS IN MYELOMA WITH END-STAGE RENAL-FAILURE
    DUVIC, C
    VIRON, B
    MICHEL, C
    MIGNON, F
    REVUE DE MEDECINE INTERNE, 1993, 14 (08): : 792 - 798
  • [23] Peritoneal dialysis for the treatment or end-stage renal failure.
    Siohan, P
    Khayat, R
    Michel, C
    Mignon, F
    SEMAINE DES HOPITAUX, 1996, 72 (7-8): : 222 - 225
  • [24] The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity
    Beltowski, J
    Wójcicka, G
    Górny, D
    Marciniak, A
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 51 (04): : 883 - 896
  • [25] Effect of renal transplantation on pulmonary function in patients with end-stage renal failure
    Chan, CHS
    Lai, CKW
    Li, PKT
    Leung, CB
    Ho, ASS
    Lai, KN
    AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (02) : 144 - 148
  • [26] Prevalence of sleep complaints in maintenance dialysis patients with end-stage renal failure in Korea
    Cho, Y
    Lee, J
    Lee, H
    SLEEP, 2003, 26 : A362 - A362
  • [27] Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure
    Traynor, JP
    Simpson, K
    Geddes, CC
    Deighan, CJ
    Fox, JG
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) : 1009 - 1009
  • [28] Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure
    Traynor, JP
    Simpson, K
    Geddes, CC
    Deighan, CJ
    Fox, JG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (08): : 2125 - 2132
  • [29] Implantable Cardioverter Defibrillator in Heart Failure Patients with End-stage Renal Disease on Dialysis
    Suzuki, Atsushi
    Shiga, Tsuyoshi
    Iwanami, Yuji
    Henmi, Ryuta
    Yagishita, Daigo
    Ejima, Koichiro
    Suzuki, Tsuyoshi
    Shoda, Morio
    Hagiwara, Nobuhisa
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S158 - S158
  • [30] Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis
    Ndlovu, Kwazi Celani Zwakele
    Chikobvu, Perpetual
    Mofokeng, Thabiso
    Gounden, Verena
    Assounga, Alain
    PLOS ONE, 2019, 14 (06):